Vaxxas awarded $5.4 million for typhoid vaccine clinical studies

Needle-free vaccine delivery company Vaxxas has announced it was awarded $5.4 million from charitable foundation Wellcome for initial studies and a  Phase I clinical trial of a potential second-generation typhoid vaccine delivered using Vaxxas’ technology. In a statement on Thursday, the Brisbane-based clinical-stage company said the project is expected to be completed within two years,…

Take action now against non-compliant imports – by Neil Clout

Australian markets are being flooded with non-compliant products that threaten both consumers and manufacturers alike. Here Neil Clout argues that weak regulations, rarely enforced are eroding Australia’s industrial and skills base. In the vast landscape of global commerce, the competition is fierce, and the stakes are high. For Australian manufacturers, the challenges are particularly daunting.…

Applications open for X-TEND WA grants

Applications will now be open year-round for funding under the Western Australian government’s X-TEND WA, a grants program aimed at growing the state’s innovation ecosystem. The competitive co-investment grants program offers funding to organisations delivering programs including those assisting in commercialisation, investor education, and co-working spaces and incubators. It formerly accepted applications within one four-week…